SynthesisFrontiers in oncology2023

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports.

Liang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.